BOSTON, October 22, 2024 -- DealEdge, the cutting-edge private equity analytics platform born from a partnership between Bain & Company and CEPRES, today announced the launch of its new Free Trial alongside a significant milestone: the platform now presents CEPRES data from 50,000 GP-reported deals, all refined according to Bain’s granular industry taxonomy. This expansive dataset, spanning from 1970 to 2024 and covering 570+ subsectors across 200+ countries, solidifies DealEdge's position as a leading source of PE deal-level intelligence.

The new Free Trial allows users to experience DealEdge's powerful Market Insights module, offering 10 complimentary searches to explore the platform's capabilities. This initiative aims to introduce more private equity professionals to the value of granular, deal-level data, which is already utilized by 75% of the top 20 PE funds globally.

"Reaching 50,000 deals is a significant milestone that sets DealEdge apart in the industry," said Dania Shaheen Gutterson, General Manager of DealEdge and Sr. Director at Bain & Co. "By launching our free trial at this pivotal moment, we're giving the entire PE community unprecedented access to this milestone achievement - 50,000 deals combined with Bain’s exclusive taxonomy. This powerful combination of extensive data and sophisticated analysis tools is a game-changer for PE firms looking to gain a competitive edge in the market. "

The Free Trial provides access to DealEdge's Market Insights module, enabling users to conduct in-depth market research, refine sector strategies, and enhance LP reporting and fundraising efforts.

Dr. Daniel Schmidt, CEO of CEPRES, commented on the milestone: "The depth and breadth of the 50,000 GP-reported deals compiled from CEPRES Market Data, offer unparalleled insights into private equity performance. This extensive dataset, combined with DealEdge's analytics, provides a powerful tool for understanding market trends and benchmarking performance."

DealEdge's analytics, powered by Bain & Company's industry expertise, offer unique value to PE professionals.

The Free Trial launch coincides with growing demand for more granular sector data for data-driven decision making in private equity. DealEdge's comprehensive platform addresses this need by offering tools for market insights, portfolio diagnostics, and pipeline analysis.

For more information on the Free Trial, please visit DealEdge.com/Free-Trial

About DealEdge

DealEdge is the premier private equity analytics platform, offering unparalleled market insights derived from a comprehensive database of 50,000+ private growth, buyout, and infrastructure strategy deals sourced directly from GPs. A strategic collaboration between Bain and CEPRES, DealEdge provides investors and advisors with critical performance metrics, operating data, and risk assessments across 570+ subsectors. Our powerful software platform, available through flexible subscription models, empowers users to make data-driven decisions in the dynamic world of private equity. For more information, visit www.dealedge.com.

About CEPRES

CEPRES is the first platform built for the age of digital transformation in private markets. Our investment data platform provides real-time and predictive analytics to unlock better investment outcomes and drive better, faster decisions. CEPRES clients leverage proprietary deal data and complete cash flows from the largest private market ecosystem, containing $50T in assets, 131,000 PE-backed companies, 13,000 funds, and 6,000 GPs and LPs. To learn more, visit us at www.cepres.com.